Prolonged-Release Mesalazine: A Review of its Therapeutic Potential in Ulcerative Colitis and Crohn's Disease

ISSN： 0012-6667

Source： Drugs, Vol.59, Iss.4, 2000-04, pp. : 929-956

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Delayed-Release Mesalazine: A Review of its Use in Ulcerative Colitis and Crohn's Disease

By Prakash A. Markham A.

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 383-408

Adis International

Access to resources Recommend Favorite

Delayed-release MMX™ mesalazine: a guide to its use in ulcerative colitis

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 24, Iss. 5, 2008-05 ,pp. : 6-8

Adis International

Access to resources Recommend Favorite

MMX® Mesalazine: A Review of its Use in the Management of Mild to Moderate Ulcerative Colitis

By Yang Lily P.H. McCormack Paul L.

Drugs, Vol. 71, Iss. 2, 2011-01 ,pp. : 221-235

Adis International

Access to resources Recommend Favorite

Delayed-Release Multi Matrix System (MMX™) Mesalazine: In Ulcerative Colitis

By McCormack Paul L. Robinson Dean M. Perry Caroline M.

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2635-2642

Adis International

Access to resources Recommend Favorite

Balsalazide: A Review of its Therapeutic Use in Mild-to-Moderate Ulcerative Colitis

By Muijsers R.B.R. Goa K.L.

Drugs, Vol. 62, Iss. 11, 2002-01 ,pp. : 1689-1705

Adis International

Access to resources Recommend Favorite